An attempt to determine if angiography (X-ray study of vessels) alone, or ultrasound and endoscopy-dictated angiography is more effective in patients who hemmhorage after a shunt has been placed into the hepatic veins to bring blood to the liver. Cirrhosis of the liver can cause the retention of fluids in over 60% of its patients. This fluid retention which does not respond to treatment can be associated with discomfort, difficulty breathing, malnutrition, liver and kidney failure, and death and increased risk of death following liver transplant. A relatively new procedure called transjugular intrahepatic portasystemic shunt (TIPS) creates a channel between veins which brings blood into the veins and out of the liver. The channel has been kept open by putting a metal tube-like structure into it. This changes the path of blood flow from the veins that are bleeding. The TIPS channel may close down due to the ingrowth of tissue into it from the surrounding liver. The chances of this occurring range from 50-60% by six months to 75-80% by one year. If this occurs, there is the risk of internal bleeding from varicose veins in the stomach and esophagus as well as a reaccumulation of fluid in the abdomen. A way to check the shunt and to repair it is very necessary. 60 patients will be admitted to the General Clinical Research Center. They will have had the TIPS procedure and lab tests will be done during the initial assessment. Patients will be randomized into two groups. TIPS must be functioning well for 7-10 days after placement. One group will have repeated angiography (x-ray of vessels after a dye has been injected into them) at six month intervals for two years during which a needle will be inserted into a neck vein and a fine tube will be threaded into the liver to measure pressure in the veins bringing blood into the liver and to check for narrowing of the shunt. The narrowing can be corrected by stretching the TIPS with a balloon and a new stent placement. Angiography will also be performed if there are clinical signs of bleeding. The second group will have repeated ultrasounds and endoscopy (an instrument insertion into a hollow organ for viewing) to view the esophagus, stomach, and upper small intestine. If problems are indicated, angiography will be performed to comfirm the findings.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
2000
Total Cost
$648
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications